2018 Regular Session
|At the request of:
|Relating to the price of prescription drugs; and declaring an emergency.
|Requires prescription drug manufacturer to report annually information to Department of Consumer and Business Services regarding prices of prescription drugs and costs associated with developing and marketing prescription drugs.
|Budget Report Issued
|No Revenue Impact
|Staff Measure Summary / Impact Statements
|Chapter Number Assigned
|Potential Conflicts of Interest/Vote Explanations:
|Potential Conflicts of Interest/Vote Explanation Documents